Deka Bank Deutsche Girozentrale Inhibrx, Inc. Put Options Transaction History
Deka Bank Deutsche Girozentrale
- $55.6 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding INBX
# of Institutions
3Shares Held
51.7KCall Options Held
0Put Options Held
0About Inhibrx, Inc.
- Ticker INBX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,057,700
- Market Cap $683M
- Description
- Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...